United States
Germany
Japan
United Kingdom
China
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Conjugates
Isotypes
Clonalities
Families
Pathways
- Acute myeloid leukemia (15)
- B cell receptor signaling pathway (15)
- Bladder cancer (15)
- Chemokine signaling pathway (15)
- Chronic myeloid leukemia (15)
- Colorectal cancer (15)
- Dorso-ventral axis formation (15)
- Endometrial cancer (15)
- ErbB signaling pathway (15)
- Fc epsilon RI signaling pathway (15)
- Fc gamma R-mediated phagocytosis (15)
- Focal adhesion (15)
- Gap junction (15)
- Glioma (15)
- GnRH signaling pathway (15)
- Insulin signaling pathway (15)
- Long-term depression (15)
- Long-term potentiation (15)
- MAPK signaling pathway (15)
- Melanogenesis (15)
- Melanoma (15)
- Natural killer cell mediated cytotoxicity (15)
- Neurotrophin signaling pathway (15)
- Non-small cell lung cancer (15)
- Oocyte meiosis (15)
- Pancreatic cancer (15)
- Pathways in cancer (15)
- Prion diseases (15)
- Progesterone-mediated oocyte maturation (15)
- Prostate cancer (15)
- Regulation of actin cytoskeleton (15)
- Renal cell carcinoma (15)
- T cell receptor signaling pathway (15)
- Thyroid cancer (15)
- Toll-like receptor signaling pathway (15)
- VEGF signaling pathway (15)
- Vascular smooth muscle contraction (15)
